News - Mergers & Acquisitions, Teva Pharmaceutical Industries

Filter

Popular Filters

Actavis forks out $100 million for Thai generics firm

Actavis forks out $100 million for Thai generics firm

02-04-2014

Ireland-headquartered US generic major Actavis has acquired Silom Medical Company, a privately held generic…

Asia-PacificAurobindo PharmaGenericsMergers & AcquisitionsSilom Medical CompanyTeva Pharmaceutical Industries

Israel's Clal Biotech in talks to sell Andromeda unit

28-02-2014

In an announcement to the Stock Exchange, Israeli firm Clal Biotechnology Industries said that, on February…

Andromeda BiotechBiotechnologyClal BiotechnologyDiabetesDiaPep277Mergers & AcquisitionsTeva Pharmaceutical Industries

NuPathe accepts Teva’s higher counter bid, rejecting Endo offer

21-01-2014

Israel-based Teva Pharmaceutical Industries seems set to bag ownership of US drugmaker NuPathe), which…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalTeva Pharmaceutical IndustriesZecuity

NuPathe receives counter offer from Teva topping Endo bid

09-01-2014

US drugmaker NuPathe – currently the subject of a takeover bid from USA-based Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNuPathePharmaceuticalTeva Pharmaceutical Industries

ANI Pharma buys 31 generic drugs from Teva

ANI Pharma buys 31 generic drugs from Teva

27-12-2013

Emerging US generic drugmaker ANI Pharmaceuticals says that it has acquired 31 previously marketed generic…

ANI PharmaceuticalsGenericsMergers & AcquisitionsTeva Pharmaceutical Industries

Teva and Lonza to discontinue their biosimilars collaboration

25-07-2013

Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA), the world's leading generics drugmaker, and…

GenericsLonzaMergers & AcquisitionsRest of the WorldTeva Pharmaceutical Industries

Teva to expand respiratory business with up to $165 million acquisition of MicroDose Therapeutx

18-06-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) has entered into a definitive agreement to acquire…

Mergers & AcquisitionsMicroDose TherapeutxPharmaceuticalRespiratory and PulmonaryTeva Pharmaceutical Industries

News briefs: US Crestor patent upheld; Pfizer animal health plans; Teva South Korea JV

17-12-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZ) said on Friday that the US Court of Appeals for the Federal…

Asia-PacificAstraZenecaCrestorGenericsHandok PharmaceuticalsLegalMergers & AcquisitionsNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesZoetis

M&A briefs: BioCryst/Presidio; Pfizer/Nestle; Teva

03-12-2012

Shares of USA-based BioCryst Pharmaceuticals (Nasdaq: BCRX) saw its shares rocket as much as 80%, before…

BioCryst PharmaceuticalsFinancialHomeMergers & AcquisitionsNestlePfizerPresidio PharmaceuticalsTeva Pharmaceutical Industries

Teva to raise stake in Rexahn; Pfizer completes NextWave deal

28-11-2012

US clinical-stage biopharma company focused on oncology and central nervous system (CNS) therapeutics…

Mergers & AcquisitionsNeurologicalNextWave PharmaceuticalsNorth AmericaOncologyPfizerPharmaceuticalQuillivantResearchRexahn PharmaceuticalsRX-3117Teva Pharmaceutical Industries

XTL Biopharma buys Teva's stake in Proteologics

28-11-2012

In a second M&A deal this year, Israel's XTL Biopharmaceuticals (TASE: XTL) announced that it has acquired…

Mergers & AcquisitionsPharmaceuticalProteologicsTeva Pharmaceutical IndustriesXTL Biopharmaceuticals

Novogen to acquire Triaxial Pharma for $1.8 million; EU approves Teva/P&G deal

13-11-2012

Biotechnology firm Novogen (ASX: NRT) yesterday announced that it has signed a term sheet in relation…

BiotechnologyMergers & AcquisitionsNovogenPharmaceuticalProcter & GambleRegulationTeva Pharmaceutical IndustriesTriaxial Pharmaceuticals

M&A briefs: GlaxoSmithKline/Response Genetics; Bayer/Teva unit

16-09-2012

USA-based Response Genetics (Nasdaq: RGDX) last week entered into a purchase agreement with UK pharma…

BayerBiotechnologyFinancialGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalResponse GeneticsTeva Pharmaceutical Industries

Teva settles Nuvigil patent litigation with Mylan, which debuts generic Doryx

01-05-2012

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world's largest generics companies, said…

Antibiotics and Infectious diseasesDoryxGenericsLegalMergers & AcquisitionsMylan LaboratoriesNeurologicalNorth AmericaNuvigilPatentsPharmaceuticalTeva Pharmaceutical IndustriesWarner Chilcott

OPKO Health buys API developer

22-12-2011

Miami, USA-based OPKO Health (NYSE: OPK), which is controlled by Israeli generics giant Teva Pharmaceutical…

FineTech PharmaceuticalGenericsMergers & AcquisitionsOPKO HealthTeva Pharmaceutical Industries

Acino buys more Cephalon/Mepha businesses

19-12-2011

Swiss branded and generic drugmaker Acino Pharma (SIX: ACIN) and Israel’s Teva Pharmaceutical Industries…

Acino PharmaCephalonGenericsMephaMergers & AcquisitionsTeva Pharmaceutical Industries

Sanofi to top Pfizer as number one for global pharma sales

01-11-2011

French drug major Sanofi (Euronext: SAN) is expected to take the top spot amongst the world’s pharmaceuticals…

FinancialGlobalJohnson & JohnsonMarkets & MarketingMerck & CoMergers & AcquisitionsNovartisNovo NordiskPfizerPharmaceuticalSanofiTakeda PharmaceuticalsTeva Pharmaceutical Industries

Acino pays 80 million euros for Cephalon’s Middle East and African business

18-10-2011

Switzerland-based generic and branded drugmaker Acino (SIX: ACIN) says it has reached agreement to acquire…

Acino PharmaCephalonGenericsMergers & AcquisitionsPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

Teva gets EU clearance for Cephalon acquisition; negative review on Azilect

14-10-2011

Following US antitrust clearance last week, Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA)…

AzilectCephalonMergers & AcquisitionsNeurologicalPharmaceuticalRegulationTeva Pharmaceutical Industries

US antitrust body OKs Teva's acquisition of Cephalon, but with divestments

10-10-2011

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) says that the US Federal Trade Commission…

CephalonGenericsLegalMergers & AcquisitionsNorth AmericaPar PharmaceuticalsPharmaceuticalProvigilTeva Pharmaceutical Industries

Teva buys out partner Kowa’s interest in Japanese JV for $150 million

27-09-2011

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world’s largest generic drugmaker,…

Asia-PacificGenericsKowa PharmaceuticalsMergers & AcquisitionsTeva Pharmaceutical Industries

Teva invests $7.5 million in Cocrystal Discovery for novel hepatitis C antiviral

18-09-2011

In a further move to boost its non-generics activities, Israel’s Teva Pharmaceutical Industries…

Anti-viralsCocrystal DiscoveryLicensingMergers & AcquisitionsPharmaceuticalRegulationTeva Pharmaceutical Industries

Teva ups stake in CureTech to 75% following positive clinical results in lymphoma

14-09-2011

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) says it is exercising its option to make an…

CureTechGenericsMergers & AcquisitionsOncologyPharmaceuticalResearchTeva Pharmaceutical Industries

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top